聚桂醇局部注射对不同年龄和部位小儿血管瘤的疗效分析

目的探讨聚桂醇注射治疗小儿血管瘤的疗效。方法回顾性分析2014年6月~2019年6月间,在江门市妇幼保健院小儿外科收治的体表血管瘤患儿90例,给予多点注射聚桂醇治疗,采用Achauer疗效评价方法进行评估,记录瘤体面积变化、取得疗效所需的时间及并发症。结果聚桂醇第一疗程总体有效率95.56%,第二疗程有效率可达100%,其中头面颈部的体表血管瘤起效最快,年龄越小效果越好。四肢的血管瘤并发症最高,达5.56%;肿胀和疼痛是最常见的并发症。结论聚桂醇局部注射治疗小儿血管瘤取得良好的临床效果,疗程短且并发症发生率低,可广泛应用于小儿体表血管瘤的治疗。

Clinical experience of local injection of lauromacrogol in the treatment of hemangioma in children

Objective To investigate the clinical efficacy of lauromacrogol injection in the treatment of hemangioma in children. Methods From June 2014 to June 2019, 90 patients diagnosed with superficial hemangioma in department of pediatric surgery, Jiangmen Maternal and Child Health Hospital were analyzed retrospectively. All of them were given lauromacrogol injection therapy. Achauer standard methods were applied to clinical effect assessment. The size of tumor, the clinical efficacy and side effects of the patient were recorded and analyzed. Results The total effective rate in the first course treatment of lauromacrogol was 95.56%, and the second course treatment was up to 100%. The superficial hemangioma in head and neck had better effects, and the younger children also had showed better therapeutic effects. The complications of hemangioma surgery in the extremities were the highest （5.56%）, in which swelling and pain were the most common. Conclusion Local injection of lauromacrogol in treatment of hemangioma in children has good clinical efficacy. The course of treatment is short and the incidence of complications is low. It can be widely used in the treatment of hemangioma in children.